BioScrip (BIOS) Tops Q4 EPS by 6c
BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $182.6 million versus the consensus estimate of $171.45 million.
BioScrip sees FY2018 revenue of $710-720 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.